| Bioactivity | Didesmethyl cariprazine is a metabolite of Cariprazine and acts as the predominant circulating active moiety. Didesmethyl cariprazine has a long half-life of 1-3 weeks. Cariprazine is a antipsychotic drug candidate that exhibits high affinity for the D3 and D2 receptors, and moderate affinity for the 5-HT1A receptor[1]. | ||||||||||||
| Name | Didesmethyl cariprazine | ||||||||||||
| CAS | 839712-25-3 | ||||||||||||
| Formula | C19H28Cl2N4O | ||||||||||||
| Molar Mass | 399.36 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Citrome L, et al. Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy. Neuropsychiatr Dis Treat. 2018 Oct 5;14:2563-2577. |
Didesmethyl cariprazine
CAS: 839712-25-3 F: C19H28Cl2N4O W: 399.36
Didesmethyl cariprazine is a metabolite of Cariprazine and acts as the predominant circulating active moiety. Didesmethy
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.